scpharmaceuticals.com (SCPH) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
scPharmaceuticals Inc. (SCPH) narxlar grafigi, tan olingan yurak yetishmovchiligini davolash usullari tufayli pul oqimi barqaror o'sib borayotgan aktiv dinamikasini namoyish etadi. Jori ko'rsatkich 0.00 ni tashkil etadi. Biznes teri ostiga yuboriladigan agentlarning tashilishi ustidan qat'iy nazoratga tayanadi, bu esa terapiya sifatini kafolatlaydi. Model bozor tebranishlariga chidamliligi orqali foyda keltiradi, chunki ushbu dori vositalariga bo'lgan talab mavsumiylikka yoki iqtisodiy sharoitlarga bog'liq emas.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_SCPH_-_scPharmaceuticals-Inc._-_Long-Term-Debt-to-Capital "SCPH: scPharma Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 18.10.2025 | 👁️GURU.Markets👁️")
scPharmaceuticals, Inc. (SCPH) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati scPharmaceuticals Inc.|SCPH - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati scPharma|SCPH - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati scPharmaceuticals Inc.|SCPH - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz scPharmaceuticals|Oraliq likvidlik koeffitsiyenti scpharmaceuticals.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:scpharmaceuticals.com - SCPH
scPharmaceuticals Inc. (SCPH) ning operatsion barqarorligini ob’ektiv baholash uchun investorlar qarz va kapital o‘rtasidagi muvozanatni tushunishlari kerak. Muddati bir yildan ortiq bo‘lgan kreditlar ulushini aks ettiruvchi uzoq muddatli qarzning kapitalga nisbati ko‘rsatkichini tahlil qilish, Furoscix ning tijorat muvaffaqiyati borasidagi noaniqliklar va cheklangan kapital bilan sug‘urta to‘lovlarini ta’minlashdagi qiyinchiliklar fonida leveraj riskini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|VRNA (Verona Pharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|Uzoq muddatli qarzning kapitalga nisbati ligand.com LGND|AMRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Liquidia Inc.|GLPG (Galapagos NV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati anipharmaceuticals.com|Uzoq muddatli qarzning o'z kapitaliga nisbati MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Pacira PCRX|ARS Corp (SPRY) - Uzoq muddatli majburiyatlarning kapitalga nisbati|TBPH: Uzoq muddatli qarzning o'z kapitaliga nisbati|aquestive.com - Uzoq muddatli kreditlarning kapitalga nisbati|TECX: Uzoq muddatli qarzning kapitalga nisbati|Tonix Pharma - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SXTC (SXT Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eupraxia Pharma EPRX|Uzoq muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Oramed Pharmaceuticals Inc. ORMP|Uzoq muddatli qarzdorlikning kapitalga nisbati Entera Bio Ltd (ENTX)|MindWalk - Uzoq muddatli qarzning kapitalga nisbati|ABVC BioPharma, Inc (ABVC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cumberland Pharmaceuticals (CPIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati QNTM (quantumbiopharma.com)|FGEN (FibroGen) - Uzoq muddatli qarzning kapitalga nisbati|TELO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati RANI|Uzoq muddatli qarzning kapitalga nisbati synergychc.com (SNYR)|Uzoq muddatli qarzning o'z kapitaliga nisbati Rallybio RLYB|Uzoq muddatli qarzning kapitalga koeffitsiyenti LEXX|PULM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pheton Holdings Ltd (PTHL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|APM: Uzoq muddatli qarzning kapitalga nisbati|Lyra Therapeutics Inc (LYRA) - Uzoq muddatli qarzning kapitalga nisbati|IBO (Impact BioMedical Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati TNF Pharma (TNFA)|Uzoq muddatli qarzning kapitalga nisbati YCBD|PRFX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Altamira Therapeutics Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Lipella Pharma LIPO|OPTN: Uzoq muddatli qarzning o'z kapitaliga nisbati|pieris.com - Uzoq muddatli kreditlarning kapitalga nisbati|PROC: Uzoq muddatli qarzning kapitalga nisbati|PTPI - Uzoq muddatli qarzdorlikning kapitalga nisbati|QLI (Qilian International Holding Group Limited) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ACELYRIN Inc. (SLRN)|Uzoq muddatli qarzning kapitalga nisbati TFFP